Virtual Reality (VR) for Prone Pain Procedures
Immersive Audiovisual Distraction With Virtual Reality (VR) in Prone Procedures in the Interventional Pain Clinic
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Michael Jung, MD MBA
- Phone Number: 916-734-7246
- Email: mijjung@ucdavis.edu
Study Contact Backup
- Name: Amaad Sulahria, DO
- Email: asulahria@ucdavis.edu
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- UC Davis Interventional Pain Clinic
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged 18 years old or older, who are referred to University of California Davis Pain Medicine Clinic and require an interventional pain procedure
- English speaking and with the ability to understand oral and written instructions
Exclusion Criteria:
- Pregnant women
- Prisoners
- Patients who have high risk of motion sickness, seizure disorder, or visual/hearing impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Virtual Reality
Patients undergo prone pain procedure with virtual reality distraction
|
Patient uses a virtual reality headset and support during prone pain procedure
Other Names:
|
|
No Intervention: Control
Patients undergo prone pain procedure without virtual reality distraction
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety Score
Time Frame: Immediately before procedure
|
State-Trait Anxiety Inventory (Self-reported anxiety instrument containing two separate 2-item subscales that measure trait (baseline) and state (situational) anxiety; Total range 20 to 80 with higher scores indicating greater anxiety).
|
Immediately before procedure
|
|
Anxiety Score
Time Frame: Immediately after procedure
|
State-Trait Anxiety Inventory (Self-reported anxiety instrument containing two separate 2-item subscales that measure trait (baseline) and state (situational) anxiety; Total range 20 to 80 with higher scores indicating greater anxiety).
|
Immediately after procedure
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety Score
Time Frame: Immediately before procedure, during procedure, and immediately after procedure
|
Anxiety score on an 11-point numerical rating scale (Total range 0-10 with higher scores indicating greater pain)
|
Immediately before procedure, during procedure, and immediately after procedure
|
|
Pain Score
Time Frame: Immediately before procedure, during procedure, and immediately after procedure
|
Pain score on an 11-point numerical rating scale (Total range 0-10 with higher scores indicating greater pain)
|
Immediately before procedure, during procedure, and immediately after procedure
|
|
Global Impression of Change
Time Frame: Immediately after procedure
|
Global Impression of Change on a 7-point scale (Lower scores indicating decline in clinical status, and higher scores indicating improvement in clinical status)
|
Immediately after procedure
|
|
Patient Experience Satisfaction
Time Frame: Immediately after procedure
|
Experience Satisfaction on an 11-point scale (Total range 0-10 with higher scores indicating higher patient experience satisfaction)
|
Immediately after procedure
|
|
Sedation Requirements
Time Frame: During course of procedure
|
Amount of benzodiazepines and opioid medications given
|
During course of procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Michael Jung, MD MBA, University of California, Davis
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 1919687
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.